Commission Implementing Regulation (EU) 2020/146 of 3 February 2020 amending Regulation (EU) No 333/2010, Implementing Regulation (EU) 2017/2312, Implementing Regulation (EU) 2018/1081, Implementing Regulation (EU) 2016/897, Implementing Regulation (EU) 2019/893 and Regulation (EU) No 184/2011 concerning the authorisations of the preparation of Bacillus subtilis C-3102 (DSM 15544) as a feed additive (Text with EEA relevance)
Amendments to Regulation (EU) No 333/2010
Regulation (EU) No 333/2010 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
Amendments to Regulation (EU) No 184/2011
Regulation (EU) No 184/2011 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
Amendments to Implementing Regulation (EU) 2016/897
Implementing Regulation (EU) 2016/897 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
Amendments to Implementing Regulation (EU) 2017/2312
Implementing Regulation (EU) 2017/2312 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’, the words ‘Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
Amendments to Implementing Regulation (EU) 2018/1081
Implementing Regulation (EU) 2018/1081 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
Amendments to Implementing Regulation (EU) 2019/893
Regulation (EU) 2019/893 is amended as follows:
(1)
in the title, the words ‘Asahi Calpis Wellness Co. Ltd, represented in the Union by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in theEuropean Union by Pen & Tec Consulting S.L.U.’;
(2)
in the second column of the Annex, ‘Name of the holder of authorisation’ the words ‘Asahi Calpis Wellness Co. Ltd, represented by Asahi Calpis Wellness Co. Ltd Europe Representative Office’ are replaced by the words ‘Asahi Calpis Wellness Co. Ltd, represented in the European Union by Pen & Tec Consulting S.L.U.’.
(3)
in column 7 ‘Minimum content’, the word ‘5 × 10 8 ’ is replaced by ‘3 × 10 8 ’.
Transitional measures
Bacillus subtilis C-3102 (DSM 15544), as set out in Regulation (EU) No 333/2010, Implementing Regulation (EU) 2017/2312, Implementing Regulation (EU) 2018/1081, Implementing Regulation (EU) 2016/897, Implementing Regulation (EU) 2019/893 and Regulation (EU) No 184/2011, and premixtures containing that substance and compound feed containing that substance, which are produced and labelled before 24 February 2020 in accordance with the rules applicable before 24 February 2020 may continue to be placed on the market and used until the existing stocks are exhausted.
Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.
